Florida cardiology ASC partners with Avertix Medical

Cardiology ASC the Heart & Rhythm Institute of Trinity (Fla.) has partnered with Avertix Medical, a company focused on improving long-term management for coronary disease patients, to make Avertix’s Guardian System available to the ASC’s patients and physicians. 

Advertisement

The Guardian System is the only FDA-approved implantable heart attack detection and warning system, according to an Aug. 16 press release. 

The device will be available to Heart & Rhythm’s 10 cardiologists who work across seven cardiology practices and seven hospitals in the area. 

Cardiologists Luis Annoni-Suau, MD, and Carlos Bayron, MD, performed the first two Guardian implant procedures at Heart & Rhythm. 

The implantable device continuously captures cardiac signals from inside the heart to provide alerts to patients and healthcare professionals 24 hours a day. It can detect acute coronary syndrome events including heart attacks, even silent and atypical symptomatic heart attacks, in real-time.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Cardiology

Advertisement

Comments are closed.